IDEX Biometrics ASA IDXAF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 164.60K | 180.60K | 69.00K | -- | 80.40K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 164.60K | 180.60K | 69.00K | -- | 80.40K |
| Cost of Revenue | 132.80K | 76.20K | 461.00K | 8.00K | 56.00K |
| Gross Profit | 31.80K | 104.40K | -392.00K | -8.00K | 24.40K |
| SG&A Expenses | 780.50K | 1.21M | 566.00K | 515.00K | 669.60K |
| Depreciation & Amortization | 35.50K | 36.10K | 69.00K | 132.00K | 139.00K |
| Other Operating Expenses | 1.23M | 1.07M | 1.03M | 975.00K | 1.69M |
| Total Operating Expenses | 2.40M | 2.70M | 2.06M | 1.98M | 3.07M |
| Operating Income | -2.24M | -2.52M | -1.99M | -1.98M | -2.99M |
| Income Before Tax | -906.10K | -3.95M | -2.80M | -992.00K | -2.02M |
| Income Tax Expenses | -- | -- | 0.00 | -- | -44.70K |
| Earnings from Continuing Operations | -906.10K | -3.95M | -2.80M | -992.00K | -1.98M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -906.10K | -3.95M | -2.80M | -992.00K | -1.98M |
| EBIT | -2.24M | -2.52M | -1.99M | -1.98M | -2.99M |
| EBITDA | -2.20M | -2.48M | -1.59M | -1.85M | -2.85M |
| EPS Basic | -0.01 | -0.06 | -0.06 | -0.02 | -0.07 |
| Normalized Basic EPS | -0.02 | -0.04 | 0.00 | -0.01 | -0.04 |
| EPS Diluted | -0.01 | -0.06 | -0.06 | -0.02 | -0.07 |
| Normalized Diluted EPS | -0.02 | -0.04 | 0.00 | -0.01 | -0.04 |
| Average Basic Shares Outstanding | 72.12M | 64.19M | 47.28M | 42.11M | 29.88M |
| Average Diluted Shares Outstanding | 72.12M | 64.19M | 47.28M | 42.11M | 29.88M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |